1 mg/1 ml clinical trials

A randomised, controlled, assessor-blind, parallel groups, multicentre, multinational trial comparing the ovarian response after controlled ovarian stimulation with mixed protocols of follitropin delta (REKOVELLE) and highly purified human menopausal gonadotropin (MENOPUR) in women undergoing an assisted reproductive technology programme

This study is looking at two different hormone medicines, Rekovelle and Menopur, used in fertility treatments like IVF. Researchers want to see which one helps women produce more good-quality eggs. It aims to improve chances of pregnancy for women needing fertility help.